Carlson Grant W
Department of Surgery, School of Medicine, Emory University, 1365C Clifton Road, Atlanta, GA 30322, USA.
Clin Plast Surg. 2016 Apr;43(2):341-7. doi: 10.1016/j.cps.2015.12.001. Epub 2016 Jan 26.
The incidence of occult breast cancer detected by reduction mammoplasty is 0.06% to 5.45%. Preoperative screening mammography is indicated in all women 40 years and older and in women age 35 with a positive family or personal history of breast cancer before reduction mammoplasty. Breast MRI is considered in women with dense breasts and those with hereditary breast cancer syndromes. Management of occult breast cancer is impacted by specimens being typically removed in pieces and not oriented before submission to pathology. Total mastectomy is the most common treatment because of the uncertainties regarding margin status and disease extent.
通过缩乳术检测出的隐匿性乳腺癌发病率为0.06%至5.45%。所有40岁及以上的女性，以及35岁且有乳腺癌家族史或个人史的女性，在进行缩乳术前均需进行术前乳腺钼靶筛查。乳房致密的女性以及患有遗传性乳腺癌综合征的女性应考虑进行乳腺磁共振成像检查。隐匿性乳腺癌的治疗受到影响，因为标本通常是分块切除的，在提交给病理科之前没有进行定位。由于切缘状态和疾病范围存在不确定性，全乳切除术是最常见的治疗方法。
